Skip to main content
Clinical Trials/DRKS00020244
DRKS00020244
Completed
Not Applicable

Follow-up study on arthrodeses of the proximal interphalangeal joint (PIP-arthrodeses) using biodegradable magnesium-based PIP implants for the treatment of lesser toe deformities.

Syntellix AG0 sites31 target enrollmentDecember 6, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
M20.4
Sponsor
Syntellix AG
Enrollment
31
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 6, 2019
End Date
February 25, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Proximal interphalangeal joint fusion of one or more lesser toes (claw toe or hammer toe) by PIP arthrodesis surgery with MAGNEZIX® StarFuse® with or without concurrent hallux valgus surgery or other associated operations.
  • Age \=18 years.
  • Written informed consent.
  • Arthrodesis surgery before October 1st, 2019

Exclusion Criteria

  • Patients unable to consent and understanding the purpose as well the consequences of this study
  • Employment relationship or other dependency with the Sponsor or investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials